Table 4.
Changes of patients’ indicators in B subgroups before and after treatment of 7 days.
| Before | After treatment of 7 days | |||||
| Variable | Group B1 | Group B2 | P | Group B1 | Group B2 | P |
| IAP (mm Hg) | 14.20 ± 2.65 | 14.33 ± 2.57 | .727∗ | 9.40 ± 1.99 | 9.52 ± 1.89 | .751∗ |
| OI (mm Hg) | 240.0 ± 73.0 | 227.1 ± 59.7 | .505∗ | 268.3 ± 67.0 | 292.4 ± 51.0 | .229† |
| RR (beats/min) | 27.6 ± 2.6 | 29.2 ± 3.7 | .158† | 22.5 ± 2.9 | 23.7 ± 2.8 | .214† |
| HR (beats/min) | 123.3 ± 7.6 | 126.1 ± 8.4 | .310† | 103.9 ± 12.7 | 102.6 ± 12.6 | .750† |
| MAP (mm Hg) | 74.1 ± 9.2 | 72.1 ± 8.2 | .477† | 80.4 ± 6.6 | 78.3 ± 7.3 | .366† |
| ALT (U/L) | 78.94 ± 29.34 | 68.64 ± 26.05 | .261† | 59.06 ± 22.69 | 55.55 ± 18.81 | .715∗ |
| TG (mmol/L) | 13.65 ± 4.00 | 11.85 ± 3.02 | .124† | 8.09 ± 2.18 | 7.09 ± 2.02 | .156† |
| CR (mmol/L) | 183.8 ± 44.2 | 190.7 ± 61.6 | .705† | 136.6 ± 48.2 | 128.5 ± 38.0 | .549∗ |
| WBC (109/L) | 11.17 ± 2.16 | 12.04 ± 2.29 | .246† | 10.53 ± 1.88 | 9.87 ± 1.92 | .300† |
| PCT (ng/mL) | 1.03 ± 0.51 | 1.26 ± 0.79 | .372∗ | 0.94 ± 0.64 | 1.00 ± 0.64 | .776† |
| IL-6 (ng/L) | 104.77 ± 23.68 | 98.09 ± 31.82 | .246∗ | 60.27 ± 26.71 | 51.82 ± 22.86 | .326∗ |
| CRP (mg/L) | 136.3 ± 44.0 | 149.3 ± 43.6 | .473∗ | 104.3 ± 30.3 | 94.7 ± 17.2 | .221† |
| APACHE II | 11.94 ± 2.41 | 12.82 ± 2.40 | .312∗ | 5.88 ± 1.36 | 6.50 ± 1.60 | .258∗ |
ALT = alanine transaminase, APACHE II = acute physiology and chronic health evaluation score II, CR = creatine, CRP = C-reactive protein, HR = heart rate, IAP = intra-abdominal pressure, IL-6 = interleukin-6, MAP = mean arterial pressure, OI = oxygenation index, PCT = procalcitonin, RR = respiratory rate, TG = triglyceride, WBC = white blood cell.
∗
Mann–Whitney test.
†
Independent samples t test.